{"id":"W2336474906","doi":"10.1177/1756283x15618130","title":"Ustekinumab for the treatment of Crohn’s disease: can it find its niche?","year":2015,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Ustekinumab; Medicine; Crohn's disease; Psoriatic arthritis; Psoriasis; Disease; Vedolizumab; Infliximab; Adalimumab; Immunology; Cohort; Secukinumab; Pharmacotherapy; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002053759,0.0004981176,0.0009710058,0.00008565706,0.00004995416,0.000008854688,0.0005482846,0.0002107685,0.00002369749],"category_scores_gemma":[0.00003211373,0.000336551,0.0004917033,0.00006019903,0.0002532294,0.000005334745,0.00007271539,0.0001077386,0.000004483559],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001358825,"about_ca_system_score_gemma":0.0003509187,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001750144,"about_ca_topic_score_gemma":0.0002601472,"domain_scores_codex":[0.9978262,0.0003315326,0.0006338849,0.0005464112,0.0001366998,0.0005253086],"domain_scores_gemma":[0.9984533,0.00008264592,0.0004439155,0.0007792715,0.0001083232,0.0001325108],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.004499904,0.0006138026,0.001095414,0.003994608,0.0008169459,0.00010256,0.0001171089,0.0003124848,0.000006756648,0.00008300354,0.0002788898,0.9880785],"study_design_scores_gemma":[0.001513058,0.0009046918,0.0007754626,0.0003209149,0.0007964322,0.00001608685,0.00002595734,0.00002495295,0.000003087672,0.00008064921,0.9953567,0.0001820168],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0009950834,0.9955255,0.0003781869,0.00008657436,0.0004217511,0.001973823,0.0005823711,0.000007404712,0.00002934495],"genre_scores_gemma":[0.001718782,0.9955281,0.00006307624,0.0002302553,0.0002878067,0.001329498,0.0003501698,0.00007080911,0.0004215162],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9950778,"threshold_uncertainty_score":0.9999086,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03938787289550029,"score_gpt":0.3510862701215244,"score_spread":0.3116983972260242,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}